Tags |
|
|
Links |
|
|
Main Subject - Innovation Management - idea selection, development and commercialisation, what are the differences?
Creativity can be defined as problem identification and idea generation whilst innovation can be defined as idea selection
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
, development and commercialisation.
There are distinct processes that enhance problem identification and idea generation
There are distinct processes that enhance problem identification and idea generation
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
and, similarly, distinct processes that enhance idea selection, development and commercialisation. Whilst there is no sur
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
fire route to commercial success, these processes improve the probability that good ideas will be generated and selected
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
and that investment in developing and commercialising those ideas will not be wasted.
There is often much confusion betwe
There is often much confusion betwe
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
n the three stages of innovation.
Idea selection seems to be pretty straightforward, and it is. Here, a critical frame of
Idea selection seems to be pretty straightforward, and it is. Here, a critical frame of
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
mind is used to reduce a quality idea pool into feasible ideas. Critical thinking is opposed to creative thinking – where
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
we use logic, reason, conservatism, feasibility and practicality to select the best ideas.
But often more than one good i
But often more than one good i
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
dea is generated. In fact, more than one good idea needs to be generated. The Economist (2003b) states that 3000 bright id
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
as are needed for 100 worthwhile projects, which in turn will be winnowed down to four development programmes for new prod
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ucts. And four such development programmes are the minimum needed to stand any chance of getting one winner.
Thus the nex
Thus the nex
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
t stage of innovation, development, involves deciding between all the good ideas. Until now, good ideas are really just on
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
y good ideas. By pushing them through stage gate processes, tinkering, experimenting, prototyping and conducting market re
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
search, it can be decided which of the good ideas are really great and worth investing in further.
Commercialisation star
Commercialisation star
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
s at the tail end of development. With four development programmes (as per the above example), other teams and competencie
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
s become more heavily involved – marketing, pricing, sales and distribution.
These topics are covered in depth in the MBA
These topics are covered in depth in the MBA
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
dissertation on Managing Creativity & Innovation, which can be purchased (along with a Creativity and Innovation DIY Audit
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
, Good Idea Generator Software and Power Point Presentation) from http://www.managing-creativity.com.
You can also receiv
You can also receiv
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
a regular, free newsletter by entering your email address at this site.
Kal Bishop, MBA
*******************************
Kal Bishop, MBA
*******************************
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
***
You are free to reproduce this article as long as no changes are made and the author's name and site URL are retained
You are free to reproduce this article as long as no changes are made and the author's name and site URL are retained
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/24265/mainsubjects-Innovation-Management--idea-selection-development-and-commercialisation-what-are-the-differences.html">Innovation Management - idea selection, development and commercialisation, what are the differences?</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/24265/mainsubjects-Innovation-Management--idea-selection-development-and-commercialisation-what-are-the-differences.html]Innovation Management - idea selection, development and commercialisation, what are the differences?[/url]
Related Articles:
Creating a Work Environment That Works
Goals 2007-Make It Your Best Year Yet!
A Tough Lesson - Customer Service Tips
Bookmark it:
|